Study for treatment of urothelial or bladder cancer

This study is for the treatment of advanced transitional cell carcinoma.

Primary disease category: Cancer

Secondary disease categories: Bladder Cancer, Kidney & Urinary Tract

Sponsor: Southwest Oncology Group

Protocol number: C90601

Projected enrollment dates: January 2014 to June 2019

Official study title: A Randomized Double-Blinded, Placebo-Controlled Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma